Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 165
Filtrar
1.
Future Med Chem ; 14(5): 325-342, 2022 03.
Artículo en Inglés | MEDLINE | ID: mdl-34985322

RESUMEN

Aim: Literature reports suggest spirochromanone derivatives exhibit anticancer activity. Methodology: The authors designed and synthesized 18 spirochromanone derivatives (Csp 1-18). The compounds were characterized and evaluated for anticancer activity against human breast cancer (MCF-7) and murine melanoma (B16F10) cell lines. Results: The anticancer activity ranged from 4.34 to 29.31 µm. The most potent compounds, Csp 12 and Csp 18, were less toxic against the human embryonic kidney (HEK-293) cell line and ∼ two/∼fourfold selective toward MCF-7 than B16F10 in comparison to the reference, BG-45. Csp 12 caused 28.6% total apoptosis, leading to significant cytotoxicity, and arrested the G2 phase of the cell cycle in B16F10 cells. A molecular docking study of Csp 12 exhibited effective binding at the active site of the epidermal growth factor receptor kinase domain. Conclusion: This study highlights the importance of spirochromanones as anticancer agents.


Asunto(s)
Antineoplásicos/síntesis química , Cromanos/química , Diseño de Fármacos , Compuestos de Espiro/química , Animales , Antineoplásicos/metabolismo , Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Sitios de Unión , Dominio Catalítico , Línea Celular Tumoral , Cromanos/metabolismo , Cromanos/farmacología , Ensayos de Selección de Medicamentos Antitumorales , Receptores ErbB/antagonistas & inhibidores , Receptores ErbB/metabolismo , Puntos de Control de la Fase G2 del Ciclo Celular/efectos de los fármacos , Humanos , Ratones , Simulación del Acoplamiento Molecular , Relación Estructura-Actividad
2.
Molecules ; 26(16)2021 Aug 04.
Artículo en Inglés | MEDLINE | ID: mdl-34443313

RESUMEN

Nowadays, products of natural origin with health-promoting properties are increasingly more common. Research shows that fruit vinegars can be a source of compounds with antioxidant activity. Research on the total antioxidant capacity, total phenolic content, and antimicrobial properties against Staphylococcus aureus, Escherichia coli, and Candida albicans of grape vinegars were conducted. Moreover, gas chromatography was used to measure acetic acid content in the vinegars. The research material consisted of vinegars produced from five different grape varieties. For each variety, two variants were prepared: with and without the addition of sugar in the fermentation process. The highest antimicrobial activity against all micro-organisms was observed in vinegar produced from Solaris grapes with added sugar. The highest polyphenol content was observed in vinegar produced from the Prior grape variety with added sugar and the highest total antioxidant capacity is the Johanniter grape variety with added sugar. The vinegars examined in this study differed, depending on grape variety, in terms of antimicrobial properties, antioxidant capacity, total phenolic content, as well as acetic acid content. Sugar addition caused significant differences in the antioxidant capacity of vinegar samples.


Asunto(s)
Ácido Acético/farmacología , Antiinfecciosos/farmacología , Antioxidantes/análisis , Antioxidantes/farmacología , Fermentación , Vitis/química , Cromanos/metabolismo , Concentración de Iones de Hidrógeno , Pruebas de Sensibilidad Microbiana , Polonia , Polifenoles/análisis
3.
J Food Biochem ; 43(2): e12707, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-31353667

RESUMEN

In the ongoing discussion on the health properties of palm oil, a study of the effect a diet supplemented with palm oil on blood and liver biochemical parameters, beta-carotene and tocochromanols content as well as antioxidant activity was undertaken. Forty Wistar rats were randomly divided into five groups, fed with a diet supplemented with plant-based frying commercial fat, palm oil, 7.5% palm oil and 2.5% concentrate from palm oil and 10% of rapeseed oil, respectively. After 21 days, blood samples and livers were collected to determine beta-carotene and tocochromanols concentrations, antioxidant activity using DPPH* radical scavenging activity and TEAC methods, insulin, glucagon, serum triacyloglycerols and cholesterol levels, glucose in blood serum and glycogen in the livers. Research has shown valuable biological properties of palm oil in terms of plasma glucose, total cholesterol, low-density lipoprotein (LDL) cholesterol, and triacylglycerol concentrations which was related to the high content of beta-carotene and tocochromanols. PRACTICAL APPLICATION: Public concern over the health properties of palm oil has been growing. Therefore, this study supplements existing knowledge in this area based on experimental rat observations. In the presented research, plasma glucose was significantly reduced and no additional growth of total or LDL cholesterol, as well as triacylglycerol concentration, was observed after consuming a palm oil-based diet. Palm oil was a good source of beta-carotene and tocochromanols, which were preferentially distributed in rats' livers. Bioavailability of vitamin E-active compounds in palm oil supplemented rats' livers was relatively high as compared to the rapeseed oil group, therefore this observation complements literature in the field of tocotrienols and tocopherols. Studies have not confirmed the harmful effect of palm oil on rats, however in depth human studies appear to be a promising direction for further research.


Asunto(s)
Antioxidantes/metabolismo , Cromanos/metabolismo , Hígado/metabolismo , Aceite de Palma/metabolismo , beta Caroteno/sangre , Animales , Colesterol/sangre , Femenino , Glucógeno/metabolismo , Masculino , Ratas , Ratas Wistar , Triglicéridos/sangre
4.
J Dairy Sci ; 102(1): 54-67, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30527978

RESUMEN

Oxidative stress caused by free radicals has been implicated in several human disorders. Dietary antioxidants can help the body to counteract those reactive species and reduce oxidative stress. Antioxidant activity is one of the multiple health-promoting attributes assigned to bovine whey products. The present study investigated whether this activity was retained during upper gut transit using a static simulated in vitro gastrointestinal digestion (SGID) model. The capacity to scavenge free radicals and reduce ferric ion of whey protein isolate (WPI), individual whey proteins, and hydrolysates pre- and post-SGID were measured and compared using various antioxidant assays. In addition, the free AA released from individual protein fractions in physiological gut conditions were characterized. Our results indicated that the antioxidant activity of WPI after exposure to the harsh conditions of the upper gut significantly increased compared with intact WPI. From an antioxidant bioactivity viewpoint, this exposure negates the need for prior hydrolysis of WPI. The whey protein α-lactalbumin showed the highest antioxidant properties post-SGID (oxygen radical absorbance capacity = 1,825.94 ± 50.21 µmol of Trolox equivalents/g of powder) of the 4 major whey proteins tested with the release of the highest amount of the antioxidant AA tryptophan, 6.955 µmol of tryptophan/g of protein. Therefore, α-lactalbumin should be the preferred whey protein in food formulations to boost antioxidant defenses.


Asunto(s)
Antioxidantes/metabolismo , Tracto Gastrointestinal/metabolismo , Proteína de Suero de Leche/metabolismo , Animales , Antioxidantes/administración & dosificación , Bromelaínas/metabolismo , Bovinos , Cromanos/administración & dosificación , Cromanos/metabolismo , Digestión , Depuradores de Radicales Libres/metabolismo , Humanos , Concentración de Iones de Hidrógeno , Hidrólisis , Lactalbúmina/metabolismo , Metaloendopeptidasas/metabolismo , Proteínas de la Leche/metabolismo , Estrés Oxidativo , Subtilisinas/metabolismo , Suero Lácteo/química , Proteína de Suero de Leche/administración & dosificación
5.
Chem Commun (Camb) ; 54(81): 11387-11390, 2018 Oct 09.
Artículo en Inglés | MEDLINE | ID: mdl-30191239

RESUMEN

In this study, we developed a multi-signal mitochondria-targeted fluorescent probe (NIR-Cys) for simultaneous detection of Cys and its metabolite, SO2. In the design of the probe, the acrylate group and the C[double bond, length as m-dash]C of the coumarin ring were used as the recognizing moiety for Cys and SO2, respectively. The probe exhibited high sensitivity, excellent specificity, and fast response. NIR-Cys was found to precisely target and visualize Cys metabolism in mitochondria of living cells with a multi-fluorescence signal. This probe is expected to be a useful tool for understanding Cys metabolism.


Asunto(s)
Acrilatos/química , Cromanos/química , Cumarinas/química , Cisteína/análisis , Colorantes Fluorescentes/química , Mitocondrias/metabolismo , Dióxido de Azufre/análisis , Acrilatos/síntesis química , Acrilatos/metabolismo , Acrilatos/toxicidad , Animales , Línea Celular Tumoral , Cromanos/síntesis química , Cromanos/metabolismo , Cromanos/toxicidad , Cumarinas/síntesis química , Cumarinas/metabolismo , Cumarinas/toxicidad , Cisteína/metabolismo , Fluorescencia , Colorantes Fluorescentes/síntesis química , Colorantes Fluorescentes/metabolismo , Colorantes Fluorescentes/toxicidad , Humanos , Límite de Detección , Hígado/metabolismo , Ratones , Microscopía Confocal/métodos , Microscopía Fluorescente/métodos , Sulfitos/análisis , Sulfitos/química , Dióxido de Azufre/metabolismo , Pez Cebra
6.
Plant Physiol ; 178(2): 535-551, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-30097469

RESUMEN

Rhododendron dauricum produces daurichromenic acid, an anti-HIV meroterpenoid, via oxidative cyclization of the farnesyl group of grifolic acid. The prenyltransferase (PT) that synthesizes grifolic acid is a farnesyltransferase in plant specialized metabolism. In this study, we demonstrated that the isoprenoid moiety of grifolic acid is derived from the 2-C-methyl-d-erythritol-4-phosphate pathway that takes place in plastids. We explored candidate sequences of plastid-localized PT homologs and identified a cDNA for this PT, RdPT1, which shares moderate sequence similarity with known aromatic PTs. RdPT1 is expressed exclusively in the glandular scales, where daurichromenic acid accumulates. In addition, the gene product was targeted to plastids in plant cells. The recombinant RdPT1 regiospecifically synthesized grifolic acid from orsellinic acid and farnesyl diphosphate, demonstrating that RdPT1 is the farnesyltransferase involved in daurichromenic acid biosynthesis. This enzyme strictly preferred orsellinic acid as a prenyl acceptor, whereas it had a relaxed specificity for prenyl donor structures, also accepting geranyl and geranylgeranyl diphosphates with modest efficiency to synthesize prenyl chain analogs of grifolic acid. Such a broad specificity is a unique catalytic feature of RdPT1 that is not shared among secondary metabolic aromatic PTs in plants. We discuss the unusual substrate preference of RdPT1 using a molecular modeling approach. The biochemical properties as well as the localization of RdPT1 suggest that this enzyme produces meroterpenoids in glandular scales cooperatively with previously identified daurichromenic acid synthase, probably for chemical defense on the surface of R. dauricum plants.


Asunto(s)
Fármacos Anti-VIH/metabolismo , Cromanos/metabolismo , Dimetilaliltranstransferasa/metabolismo , Farnesiltransferasa/metabolismo , VIH/efectos de los fármacos , Rhododendron/enzimología , Fármacos Anti-VIH/química , Cromanos/química , Clonación Molecular , Ciclización , Dimetilaliltranstransferasa/genética , Farnesiltransferasa/genética , Modelos Moleculares , Oxidación-Reducción , Filogenia , Proteínas de Plantas/genética , Proteínas de Plantas/metabolismo , Plastidios/enzimología , Rhododendron/genética , Sesterterpenos/química , Sesterterpenos/metabolismo
7.
Bioorg Med Chem ; 26(12): 3438-3452, 2018 07 23.
Artículo en Inglés | MEDLINE | ID: mdl-29803359

RESUMEN

In this study, novel 3-O-methoxy-4-halo, disubstituted-5,7-dimethoxy chromans with bacterial cell wall degrading potentials were synthesized, characterized and evaluated as DNA gyrase inhibitors and antibacterial agents. Compounds were showed a broad spectrum of antimicrobial activity against both Gram+ve bacteria (S. aureus (MTCC 3160), C. diphtheriae (MTCC 116), S. pyogenes (MTCC 442)) and Gram-ve bacteria (E. coli (MTCC 443), P. aeruginosa (MTCC 424), K. pneumoniae (MTCC 530)). Further, a molecular docking study was carried out to get more insight into the binding mode of present study compounds to target proteins (PDB ID: 2XCT (S. aureus DNA gyrase A), PDB ID: 3G75 (S. aureus DNA gyrase B), PDB ID: 3L7L (Teichoic acid polymerase). In the results, 14 > 20 > 24 > 12 > 18 > 17 were found as the most active against almost all executed activities in this study. The predicted Lipinski's filter scores, SAR, pharmacokinetic/pharmacodynamics, and ADMET properties of these compounds envisioned the druggability prospects and the necessity of further animal model evaluations of 3-O-methoxy-4-halo disubstituted 5,7-dimethoxy chromans to establish them as an effective and future antibiotics.


Asunto(s)
Antibacterianos/química , Cromanos/química , Girasa de ADN/metabolismo , Inhibidores de Topoisomerasa II/química , Antibacterianos/metabolismo , Antibacterianos/farmacología , Sitios de Unión , Dominio Catalítico , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Pared Celular/efectos de los fármacos , Pared Celular/metabolismo , Cromanos/metabolismo , Cromanos/farmacología , Girasa de ADN/química , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Humanos , Pruebas de Sensibilidad Microbiana , Simulación del Acoplamiento Molecular , Relación Estructura-Actividad , Inhibidores de Topoisomerasa II/metabolismo , Inhibidores de Topoisomerasa II/farmacología
8.
J Pharmacol Exp Ther ; 364(2): 275-286, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29180359

RESUMEN

Tegoprazan [(S)-4-((5,7-difluorochroman-4-yl)oxy)-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide], a potassium-competitive acid blocker (P-CAB), is a novel potent and highly selective inhibitor of gastric H+/K+-ATPase. Tegoprazan inhibited porcine, canine, and human H+/K+-ATPases in vitro with IC50 values ranging from 0.29 to 0.52 µM, while that for canine kidney Na+/K+-ATPase was more than 100 µM. A kinetic analysis revealed that tegoprazan inhibited H+/K+-ATPase in a potassium-competitive manner and the binding was reversible. Oral single administrations of tegoprazan ranging from 0.3 to 30 mg/kg in dogs were well absorbed into the blood stream and distributed in gastric tissue/fluid higher than in plasma. Tegoprazan potently inhibited histamine-induced gastric acid secretion in dogs, and a complete inhibition was observed at 1.0 mg/kg starting from 1 hour after administration. Moreover, an oral administration of tegoprazan at 1 and 3 mg/kg reversed the pentagastrin-induced acidified gastric pH to the neutral range. Interestingly, 3 mg/kg tegoprazan immediately evoked a gastric phase III contraction of the migrating motor complex in pentagastrin-treated dogs and similar effects was observed with the other P-CAB, vonoprazan. Tegoprazan is the novel P-CAB that may provide a new option for the therapy of gastric acid-related and motility-impaired diseases.


Asunto(s)
Derivados del Benceno/farmacología , Cromanos/farmacología , Ácido Gástrico/metabolismo , Motilidad Gastrointestinal/efectos de los fármacos , Imidazoles/farmacología , Potasio/metabolismo , Inhibidores de la Bomba de Protones/farmacología , Animales , Cromanos/metabolismo , Perros , Jugo Gástrico/efectos de los fármacos , Jugo Gástrico/metabolismo , ATPasa Intercambiadora de Hidrógeno-Potásio/metabolismo , Células HEK293 , Humanos , Concentración de Iones de Hidrógeno , Imidazoles/metabolismo , Pentagastrina/farmacología , Inhibidores de la Bomba de Protones/metabolismo , Estómago/efectos de los fármacos , Estómago/fisiología , Porcinos
9.
J Nutr Sci Vitaminol (Tokyo) ; 63(5): 349-354, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29225320

RESUMEN

Tocotrienols (T3s) and tocopherols (Tocs) are both members of the vitamin E family. It is known that δ-tocotrienol (δ-T3) has displayed the most potent anti-cancer activity amongst the tocotrienols. On the other hand, γ-tocopherol (γ-Toc) is reported to have a protective effect against prostate cancer. Therefore, we investigated whether the combination of γ-Toc and δ-T3 could strengthen the inhibitory effect of δ-T3 on prostate cancer cell growth. In this study the effect of combined δ-T3 (annatto T3 oil) and γ-Toc (Tmix, γ-Toc-rich oil) therapy was assessed against human androgen-dependent prostate cancer cells (LNCaP). We found that combined treatment of δ-T3 (10 µM) and γ-Toc (5 µM) resulted in reinforced anti-prostate cancer activity. Specifically, cell cycle phase distribution analysis revealed that in addition to G1 arrest caused by the treatment with δ-T3, the combination of δ-T3 with γ-Toc induced G2/M arrest. Enhanced induction of apoptosis by the combined treatment was also observed. These findings indicate that combination of δ-T3 and γ-Toc significantly inhibits prostate cancer cell growth due to the simultaneous cell cycle arrest in the G1 phase and G2/M phase.


Asunto(s)
Anticarcinógenos/metabolismo , Antineoplásicos Fitogénicos/agonistas , Apoptosis , Cromanos/agonistas , Neoplasias de la Próstata/metabolismo , Vitamina E/análogos & derivados , Anticarcinógenos/química , Antineoplásicos Fitogénicos/metabolismo , Bixaceae/metabolismo , Carotenoides/agonistas , Carotenoides/metabolismo , Línea Celular Tumoral , Proliferación Celular , Supervivencia Celular , Cromanos/metabolismo , Fase G1 , Fase G2 , Humanos , Masculino , Concentración Osmolar , Extractos Vegetales/agonistas , Extractos Vegetales/metabolismo , Neoplasias de la Próstata/patología , Neoplasias de la Próstata Resistentes a la Castración/metabolismo , Neoplasias de la Próstata Resistentes a la Castración/patología , Vitamina E/agonistas , Vitamina E/metabolismo
10.
Food Funct ; 8(12): 4630-4643, 2017 Dec 13.
Artículo en Inglés | MEDLINE | ID: mdl-29147700

RESUMEN

The present study was aimed to investigate the impacts of brown rice (BR) and retrograded brown rice (R-BR) consumption on colonic health and gut microbiota in dextran sulfate sodium (DSS) induced colitis mice. Thirty two female C57Bl/6Mlac mice were fed with modified AIN 93G diets by replacing cornstarch in the original composition with white rice (WR), BR and R-BR powder. The mice were divided into 4 groups and fed with the following experimental diets for 4 weeks: (1) negative control (WR: diet with WR), (2) positive control (DSS_WR: DSS and diet with WR), (3) DSS_BR: DSS and diet with BR, and (4) DSS_R-BR: DSS and diet with R-BR. BR and R-BR had a greater content of fat, dietary fiber, GABA, γ-oryzanol, γ-tocotrienol, ferulic acid and p-coumaric acid than WR (p < 0.05). No significant difference in the level of these bioactive compounds was noted between BR and R-BR. Nevertheless, R-BR had a 1.8 fold resistant starch (RS) content of BR (p < 0.05). The DSS_BR and DSS_R-BR groups showed a lower ratio of colonic weight to length, and a lower content of iNOS, COX-2, MPO, IL-6 and INF-γ in colonic homogenates than the DSS_WR group. However, the DSS treated mice fed with the R-BR diet had significantly milder histopathological inflammatory injury and lower colonic iNOS expression than the DSS_BR and DSS_WR groups. The percentage of mesenteric regulatory T cells significantly increased in the DSS_R-BR group compared to that in the DSS_WR group. The DSS treated mice fed with the R-BR diet showed a significant increase in cecal bacterial diversity and abundance of genera Prevotella, Ruminococcus, Dorea, Coprococcus and Dehalobacterium but a significant decrease in pathogenic bacteria including Bacteroides and Enterococcus compared to the DSS_WR group. Thus, the present data indicate that BR and R-BR ameliorate colonic inflammation in experimental colitis induced by DSS in mice by suppressing inflammatory mediators and modulating regulatory T cell responses as well as bacterial diversity in the cecum.


Asunto(s)
Colitis/dietoterapia , Colitis/inmunología , Oryza/metabolismo , Animales , Ciego/inmunología , Ciego/metabolismo , Cromanos/análisis , Cromanos/metabolismo , Colitis/inducido químicamente , Colitis/metabolismo , Ciclooxigenasa 2/genética , Ciclooxigenasa 2/inmunología , Sulfato de Dextran/efectos adversos , Femenino , Humanos , Interferón gamma/genética , Interferón gamma/inmunología , Interleucina-6/genética , Interleucina-6/inmunología , Ratones , Ratones Endogámicos C57BL , Oryza/química , Fenilpropionatos/análisis , Fenilpropionatos/metabolismo , Vitamina E/análogos & derivados , Vitamina E/análisis , Vitamina E/metabolismo
11.
Plant Physiol ; 174(4): 2213-2230, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28679557

RESUMEN

Daurichromenic acid (DCA) synthase catalyzes the oxidative cyclization of grifolic acid to produce DCA, an anti-HIV meroterpenoid isolated from Rhododendron dauricum We identified a novel cDNA encoding DCA synthase by transcriptome-based screening from young leaves of R. dauricum The gene coded for a 533-amino acid polypeptide with moderate homologies to flavin adenine dinucleotide oxidases from other plants. The primary structure contained an amino-terminal signal peptide and conserved amino acid residues to form bicovalent linkage to the flavin adenine dinucleotide isoalloxazine ring at histidine-112 and cysteine-175. In addition, the recombinant DCA synthase, purified from the culture supernatant of transgenic Pichia pastoris, exhibited structural and functional properties as a flavoprotein. The reaction mechanism of DCA synthase characterized herein partly shares a similarity with those of cannabinoid synthases from Cannabis sativa, whereas DCA synthase catalyzes a novel cyclization reaction of the farnesyl moiety of a meroterpenoid natural product of plant origin. Moreover, in this study, we present evidence that DCA is biosynthesized and accumulated specifically in the glandular scales, on the surface of R. dauricum plants, based on various analytical studies at the chemical, biochemical, and molecular levels. The extracellular localization of DCA also was confirmed by a confocal microscopic analysis of its autofluorescence. These data highlight the unique feature of DCA: the final step of biosynthesis is completed in apoplastic space, and it is highly accumulated outside the scale cells.


Asunto(s)
Fármacos Anti-VIH/metabolismo , Vías Biosintéticas , Cromanos/metabolismo , Ligasas/metabolismo , Biocatálisis , Cromatografía Líquida de Alta Presión , Clonación Molecular , Electroforesis en Gel de Poliacrilamida , Regulación de la Expresión Génica de las Plantas , Proteínas Fluorescentes Verdes/metabolismo , Cinética , Ligasas/genética , Oxígeno/metabolismo , Filogenia , Fitoquímicos/metabolismo , Pichia/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Proteínas Recombinantes/metabolismo , Rhododendron/citología , Rhododendron/genética , Rhododendron/metabolismo , Homología Estructural de Proteína , Nicotiana/citología
12.
Am J Clin Nutr ; 105(3): 571-579, 2017 03.
Artículo en Inglés | MEDLINE | ID: mdl-28077381

RESUMEN

Background: Vitamin E supplementation improves liver histology in patients with nonalcoholic steatohepatitis, which is a manifestation of the metabolic syndrome (MetS). We reported previously that α-tocopherol bioavailability in healthy adults is higher than in those with MetS, thereby suggesting that the latter group has increased requirements.Objective: We hypothesized that α-tocopherol catabolites α-carboxyethyl hydroxychromanol (α-CEHC) and α-carboxymethylbutyl hydroxychromanol (α-CMBHC) are useful biomarkers of α-tocopherol status.Design: Adults (healthy or with MetS; n = 10/group) completed a double-blind, crossover clinical trial with four 72-h interventions during which they co-ingested 15 mg hexadeuterium-labeled RRR-α-tocopherol (d6-α-T) with nonfat, reduced-fat, whole, or soy milk. During each intervention, we measured α-CEHC and α-CMBHC excretions in three 8-h urine collections (0-24 h) and plasma α-tocopherol, α-CEHC, and α-CMBHC concentrations at various times ≤72 h.Results: During the first 24 h, participants with MetS compared with healthy adults excreted 41% less α-CEHC (all values are least-squares means ± SEMs: 0.6 ± 0.1 compared with 1.0 ± 0.1 µmol/g creatinine, respectively; P = 0.002), 63% less hexadeuterium-labeled (d6)-α-CEHC (0.04 ± 0.02 compared with 0.13 ± 0.02 µmol/g creatinine, respectively; P = 0.002), and 58% less d6-α-CMBHC (0.017 ± 0.004 compared with 0.041 ± 0.004 µmol/g creatinine, respectively; P = 0.0009) and had 52% lower plasma d6-α-CEHC areas under the concentration curves [area under the curve from 0 to 24 h (AUC0-24h): 27.7 ± 7.9 compared with 58.4 ± 7.9 nmol/L × h, respectively; P = 0.01]. d6-α-CEHC peaked before d6-α-T in 77 of 80 paired plasma concentration curves. Urinary d6-α-CEHC 24-h concentrations were associated with the plasma AUC0-24 h of d6-α-T (r = 0.53, P = 0.02) and d6-α-CEHC (r = 0.72, P = 0.0003), and with urinary d6-α-CMBHC (r = 0.88, P < 0.0001), and inversely with the plasma inflammation biomarkers C-reactive protein (r = -0.70, P = 0.0006), interleukin-10 (r = -0.59, P = 0.007), and interleukin-6 (r = -0.54, P = 0.01).Conclusion: Urinary α-CEHC and α-CMBHC are useful biomarkers to noninvasively assess α-tocopherol adequacy, especially in populations with MetS-associated hepatic dysfunction that likely impairs α-tocopherol trafficking. This trial was registered at clinicaltrials.gov as NCT01787591.


Asunto(s)
Cromanos/metabolismo , Síndrome Metabólico/metabolismo , Necesidades Nutricionales , Estado Nutricional , Ácidos Pentanoicos/metabolismo , alfa-Tocoferol/metabolismo , Adulto , Área Bajo la Curva , Biomarcadores/sangre , Biomarcadores/orina , Proteína C-Reactiva/metabolismo , Cromanos/sangre , Cromanos/orina , Creatinina/orina , Estudios Cruzados , Método Doble Ciego , Femenino , Humanos , Inflamación/sangre , Interleucina-10/sangre , Interleucina-6/sangre , Hígado/patología , Masculino , Síndrome Metabólico/patología , Ácidos Pentanoicos/sangre , Ácidos Pentanoicos/orina , Adulto Joven
13.
Mol Nutr Food Res ; 61(3)2017 03.
Artículo en Inglés | MEDLINE | ID: mdl-27714977

RESUMEN

SCOPE: Members of the vitamin E family or their metabolites may induce the xenobiotic transporter P-glycoprotein (P-gp), which can limit the bioavailability of drugs and phytochemicals. This study aimed to investigate if α- and γ-tocopherol, α- and γ-tocotrienol, the long chain metabolite α-tocopherol-13'-COOH, the short chain metabolites α- and γ-carboxyethylhydroxychromanol and plastochromanol-8 activate the pregnane X receptor (PXR) and thereby modulate P-gp expression and/or activity. METHODS AND RESULTS: P-gp protein expression and activity were studied in LS 180 cells incubated with the respective test compound for 48 h. Furthermore, we determined if the compounds activate PXR in LS 180 cells, as PXR regulates P-gp expression. Neither P-gp protein expression and activity, nor PXR activity were influenced by α-tocopherol, γ-tocopherol and plastochromanol-8. α-Tocotrienol activated PXR in the reporter gene assay but did not induce protein expression or activity of P-gp. γ-Tocotrienol and α-13'-COOH activated PXR and induced protein expression and transporter activity of P-gp. CONCLUSION: Because the induction of P-gp in the intestine may limit the systemic bioavailability of its substrates, the concurrent intake of drugs and γ-tocotrienol and, if ever applicable, α-13'-COOH should be avoided.


Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/metabolismo , Benzopiranos/farmacología , Cromanos/farmacología , Ácidos Grasos/farmacología , Receptores de Esteroides/metabolismo , Vitamina E/análogos & derivados , Benzopiranos/metabolismo , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Cromanos/metabolismo , Ácidos Grasos/metabolismo , Humanos , Intestinos , Receptor X de Pregnano , Receptores de Esteroides/genética , Vitamina E/metabolismo , Vitamina E/farmacología , alfa-Tocoferol/farmacocinética , gamma-Tocoferol/farmacocinética
14.
J Physiol Biochem ; 73(1): 59-65, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27743340

RESUMEN

Human diploid fibroblasts (HDFs) proliferation in culture has been used as a model of aging at the cellular level. Growth arrest is one of the most important mechanisms responsible for replicative senescence. Recent researches have been focusing on the function of vitamin E in modulating cellular signaling and gene expression. Therefore, the aim of this study was to elucidate the effect of palm γ-tocotrienol (vitamin E) in modulating cellular aging through p16INK4a pathway in HDF cells. Primary culture of senescent HDFs was incubated with 70 µM of palm γ-tocotrienol for 24 hours. Silencing of p16INK4a was carried out by siRNA transfection. RNA was extracted from the different treatment groups and gene expression analysis was carried out by real-time reverse transcription polymerase chain reaction. Proteins that were regulated by p16INK4a were determined by western blot technique. The finding of this study showed that p16INK4a mRNA was overexpressed in senescent HDFs, and hypophosphorylated-pRb and cyclin D1 protein expressions were increased (p < 0.05). However, downregulation of p16INK4a and hypophosphorylated-pRb and cyclin D1 protein expressions (p < 0.05) by γ-tocotrienol led to modulation of the cell cycle regulation during cellular aging. In conclusion, senescent HDFs showed change in biological process specifically in cell cycle regulation with elevated expression of genes and proteins which may contribute to cell cycle arrest. Palm γ-tocotrienol may delay cellular senescence of HDFs by regulating cell cycle through downregulation of p16INK4a and hypophosphorylated-pRb and cyclin D1 protein expressions.


Asunto(s)
Senescencia Celular , Cromanos/metabolismo , Ciclina D1/antagonistas & inhibidores , Inhibidor p16 de la Quinasa Dependiente de Ciclina/antagonistas & inhibidores , Regulación hacia Abajo , Fibroblastos/metabolismo , Proteínas de Unión a Retinoblastoma/antagonistas & inhibidores , Ubiquitina-Proteína Ligasas/antagonistas & inhibidores , Vitamina E/análogos & derivados , Ciclo Celular , Proliferación Celular , Células Cultivadas , Niño , Ciclina D1/genética , Ciclina D1/metabolismo , Inhibidor p16 de la Quinasa Dependiente de Ciclina/genética , Inhibidor p16 de la Quinasa Dependiente de Ciclina/metabolismo , Fibroblastos/citología , Fibroblastos/enzimología , Prepucio/citología , Regulación de la Expresión Génica , Humanos , Masculino , Fosforilación , Procesamiento Proteico-Postraduccional , Interferencia de ARN , ARN Interferente Pequeño , Proteínas de Unión a Retinoblastoma/genética , Proteínas de Unión a Retinoblastoma/metabolismo , Transducción de Señal , Ubiquitina-Proteína Ligasas/genética , Ubiquitina-Proteína Ligasas/metabolismo , Vitamina E/metabolismo
15.
Bioorg Med Chem Lett ; 26(16): 4003-6, 2016 08 15.
Artículo en Inglés | MEDLINE | ID: mdl-27397500

RESUMEN

Many adverse drug reactions are caused by the cytochrome P450 (CYP)-dependent activation of drugs into reactive metabolites. In order to reduce attrition due to metabolism-induced toxicity and to improve the safety of drug candidates, we developed a simple cell viability assay by combining a bioactivation system (human CYP3A4, CYP2D6 and CYP2C9) with Hep3B cells. We screened a series of drugs to explore structural motifs that may be responsible for CYP450-dependent activation caused by reactive metabolite formation, which highlighted specific liabilities regarding certain phenols and anilines.


Asunto(s)
Sistema Enzimático del Citocromo P-450/metabolismo , Preparaciones Farmacéuticas/metabolismo , Adenosina Trifosfato/metabolismo , Benzbromarona/análogos & derivados , Benzbromarona/metabolismo , Benzbromarona/toxicidad , Línea Celular , Supervivencia Celular/efectos de los fármacos , Cromanos/metabolismo , Cromanos/toxicidad , Citocromo P-450 CYP2C9/metabolismo , Citocromo P-450 CYP2D6/metabolismo , Citocromo P-450 CYP3A/metabolismo , Humanos , Tiazolidinedionas/metabolismo , Tiazolidinedionas/toxicidad , Troglitazona
16.
Chem Commun (Camb) ; 51(66): 13113-6, 2015 Aug 25.
Artículo en Inglés | MEDLINE | ID: mdl-26186061

RESUMEN

The enantioselective preparation of pharmacologically interesting chroman-fused spirooxindole derivatives is described based on an organocatalytic multicomponent cascade reaction. The compounds synthesized using this method potently inhibited the proliferation of various cancer cell lines. The most potent compound (7e) induced caspase-independent apoptosis and cell cycle arrest in MCF-7 breast cancer cells by interfering with the p53-MDM2 interaction and downstream pathways.


Asunto(s)
Antineoplásicos/química , Antineoplásicos/farmacología , Cromanos/química , Cromanos/farmacología , Indoles/química , Antineoplásicos/síntesis química , Antineoplásicos/metabolismo , Apoptosis/efectos de los fármacos , Catálisis , Puntos de Control del Ciclo Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Técnicas de Química Sintética , Cromanos/síntesis química , Cromanos/metabolismo , Humanos , Células MCF-7 , Modelos Moleculares , Conformación Proteica , Proteínas Proto-Oncogénicas c-mdm2/química , Proteínas Proto-Oncogénicas c-mdm2/metabolismo , Proteína p53 Supresora de Tumor/metabolismo
17.
BMC Complement Altern Med ; 15: 64, 2015 Mar 13.
Artículo en Inglés | MEDLINE | ID: mdl-25886747

RESUMEN

BACKGROUND: To determine the antiproliferative effect of gamma-tocotrienol (GTT) treatment on differential protein expression in HepG2 cells. METHODS: HepG2 cells were treated with 70 µM GTT for 48 hours and differentially expressed protein spots were determined by two-dimensional electrophoresis (2DE), identified by MALDI-TOF mass spectrometer (MS) and validated by quantitative real-time polymerase chain reaction (qRT-PCR). RESULTS: GTT treatment on HepG2 cells showed a total of five differentially expressed proteins when compared to their respective untreated cells where three proteins were down-regulated and two proteins were up-regulated. One of these upregulated proteins was identified as peroxiredoxin-4 (Prx4). Validation by qRT-PCR however showed decreased expression of Prx4 mRNA in HepG2 cells following GTT treatment. CONCLUSIONS: GTT might directly influence the expression dynamics of peroxiredoxin-4 to control proliferation in liver cancer.


Asunto(s)
Antineoplásicos/farmacología , Antioxidantes/farmacología , Hepatoblastoma/metabolismo , Neoplasias Hepáticas/metabolismo , Hígado/efectos de los fármacos , Peroxirredoxinas/metabolismo , Tocotrienoles/farmacología , Antineoplásicos/uso terapéutico , Antioxidantes/uso terapéutico , Neoplasias de los Conductos Biliares , Cromanos/metabolismo , Regulación hacia Abajo , Electroforesis en Gel Bidimensional , Células Hep G2 , Hepatoblastoma/tratamiento farmacológico , Humanos , Hígado/metabolismo , Neoplasias Hepáticas/tratamiento farmacológico , Proteínas/metabolismo , Proteómica , ARN Mensajero/metabolismo , Reacción en Cadena en Tiempo Real de la Polimerasa , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Tocotrienoles/uso terapéutico , Regulación hacia Arriba , Vitamina E/análogos & derivados , Vitamina E/metabolismo , Vitaminas/farmacología , Vitaminas/uso terapéutico
18.
Int J Obes (Lond) ; 39(3): 438-46, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25042861

RESUMEN

BACKGROUND AND OBJECTIVE: We have previously demonstrated that gamma tocotrienol (γT3) potently inhibits adipocyte hyperplasia in human adipose-derived stem cells (hASCs). In this study, our objective was to investigate the γT3 effects on early-onset obesity, inflammation and insulin resistance in vivo. METHODS: Young C57BL/6J mice were fed a high-fat (HF) diet supplemented with 0.05% γT3 for 4 weeks. The concentrations of γT3 in plasma and adipose tissue were measured using high-performance liquid chromatography. Effects of γT3 on body weight gain, adipose volume, plasma levels of fasting glucose, insulin (enzyme-linked immunosorbent assay (ELISA)), proinflammatory cytokines (mouse cytokine array), insulin signaling (western blotting) and gene expression (quantitative real-time PCR, qPCR) in the liver and adipose tissue were examined. Influences of γT3 on [3H]-2-deoxyglucose uptake and lipopolysaccharide (LPS)-mediated NFκB signaling (western blotting) were assessed in hASCs. Effects of γT3 on macrophage M1/M2 activation were investigated using qPCR in mouse bone marrow-derived macrophages. RESULTS: After a 4-week treatment, γT3 accumulated in adipose tissue and reduced HF diet-induced weight gain in epididymal fat, mesenteric fat and the liver. Compared with HF diet-fed mice, HF+γT3-fed mice were associated with (1) decreased plasma levels of fasting glucose, insulin and proinflammatory cytokines, (2) improved glucose tolerance and (3) enhanced insulin signaling in adipose tissue. There were substantial decreases in macrophage specific markers, and monocyte chemoattractant protein-1, indicating that γT3 reduced the recruitment of adipose tissue macrophages (ATMs). In addition, γT3 treatment in human adipocytes resulted in (1) activation of insulin-stimulated glucose uptake and (2) a significant suppression of MAP kinase and NFκB activation. In parallel, γT3 treatment led to a reduction of LPS-mediated M1 macrophage polarization. CONCLUSION: Our results demonstrated that γT3 ameliorates HF diet-mediated obesity and insulin resistance by inhibiting systemic and adipose inflammation, as well as ATM recruitment.


Asunto(s)
Tejido Adiposo/metabolismo , Fármacos Antiobesidad/farmacología , Cromanos/farmacología , Resistencia a la Insulina , Activación de Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Obesidad/prevención & control , Vitamina E/análogos & derivados , Animales , Fármacos Antiobesidad/metabolismo , Western Blotting , Cromanos/metabolismo , Dieta Alta en Grasa , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Inflamación/etiología , Inflamación/prevención & control , Masculino , Ratones , Ratones Endogámicos C57BL , Obesidad/etiología , Reacción en Cadena en Tiempo Real de la Polimerasa , Vitamina E/metabolismo , Vitamina E/farmacología
19.
Biochim Biophys Acta ; 1841(12): 1741-51, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25462452

RESUMEN

Vitamin E membrane transport has been shown to involve the cholesterol transporters SR-BI, ABCA1 and NPC1L1. Our aim was to investigate the possible participation of another cholesterol transporter in cellular vitamin E efflux: ABCG1. In Abcgl-deficient mice, vitamin E concentration was reduced in plasma lipoproteins whereas most tissues displayed a higher vitamin E content compared to wild-type mice. α- and γ-tocopherol efflux was increased in CHO cells overexpressing human ABCG1 compared to control cells. Conversely, α- and γ- tocopherol efflux was decreased in ABCG1-knockdown human cells (Hep3B hepatocytes and THP-1 macro- phages). Interestingly, α- and γ-tocopherol significantly downregulated ABCG1 and ABCA1 expression levels in Hep3B and THP-1, an effect confirmed in vivo in rats given vitamin E for 5 days. This was likely due to reduced LXR activation by oxysterols, as Hep3B cells and rat liver treated with vitamin E displayed a significantly reduced content in oxysterols compared to their respective controls. Overall, the present study reveals for the first time that ABCG1 is involved in cellular vitamin E efflux.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/metabolismo , Lipoproteínas/metabolismo , Vitamina E/metabolismo , Transportador 1 de Casete de Unión a ATP/genética , Transportador 1 de Casete de Unión a ATP/metabolismo , Transportador de Casetes de Unión a ATP, Subfamilia G, Miembro 1 , Transportadoras de Casetes de Unión a ATP/deficiencia , Transportadoras de Casetes de Unión a ATP/genética , Animales , Transporte Biológico , Células CHO , Cromanos/metabolismo , Cricetinae , Cricetulus , Regulación hacia Abajo , Humanos , Lipoproteínas/deficiencia , Hígado/metabolismo , Receptores X del Hígado , Macrófagos/metabolismo , Ratones Endogámicos C57BL , Especificidad de Órganos , Receptores Nucleares Huérfanos/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , ARN Interferente Pequeño/metabolismo , Ratas , Transfección
20.
Southeast Asian J Trop Med Public Health ; 45(5): 1015-22, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25417502

RESUMEN

An alteration in the oxidation/reduction (redox) status of humans infected with virus infections may contrioute to tefl pariiogeiiesin anu ciniiua1 manifestations of the disease. Alterations in redox markers begin prior to the onset of clinical symptoms, suggesting early changes in the oxidant/antioxidant balance. Early identification of redox markers may be of clinical usefulness in the management of patients with dengue virus infection. We conducted a hospital based comparative cross sectional study of 55 patients serologically confirmed to have dengue infection and 55 clinically healthy age and sex matched subjects as controls to assess oxidative stress in acute dengue virus infection. Blood samples were drawn on the fifth day after symptom onset and analyzed for Trolox equivalent antioxidant capacity (TEAC), reduced glutathione (GSH), glutathione peroxidase (GPx) and paraoxonase (PON) activity. The results showed significantly lower levels of plasma TEAC, serum PON and erythrocyte GSH and GPx activity among dengue patients than in controls. Of the antioxidants investigated, PON appeared to be the most sensitive marker of oxidative stress in dengue virus infection. Serum PON may be a potentially useful marker of oxidative stress in patients with dengue virus infection.


Asunto(s)
Antioxidantes/metabolismo , Dengue/metabolismo , Arildialquilfosfatasa/metabolismo , Biomarcadores , Cromanos/metabolismo , Estudios Transversales , Dengue/sangre , Femenino , Glutatión/metabolismo , Glutatión Peroxidasa/metabolismo , Humanos , Masculino , Oxidación-Reducción
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA